300 related articles for article (PubMed ID: 32414426)
1. Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2-agonist in real-world patients with asthma.
Chipps B; Mosnaim G; Mathur SK; Shaikh A; Khoury S; Gopalan G; Palli SR; Lamerato L; Casciano J; Dotiwala Z; Settipane R
Allergy Asthma Proc; 2020 Jul; 41(4):248-255. PubMed ID: 32414426
[No Abstract] [Full Text] [Related]
2. Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization.
Hanania NA; Settipane RA; Khoury S; Shaikh A; Dotiwala Z; Casciano J; Foggs MB
Allergy Asthma Proc; 2023 Nov; 44(6):413-421. PubMed ID: 37919843
[No Abstract] [Full Text] [Related]
3. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
Kew KM; Dahri K
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
[TBL] [Abstract][Full Text] [Related]
4. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.
Wechsler ME; Yawn BP; Fuhlbrigge AL; Pace WD; Pencina MJ; Doros G; Kazani S; Raby BA; Lanzillotti J; Madison S; Israel E;
JAMA; 2015 Oct; 314(16):1720-30. PubMed ID: 26505596
[TBL] [Abstract][Full Text] [Related]
5. Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.
Rojas-Reyes MX; García Morales OM; Dennis RJ; Karner C
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD008532. PubMed ID: 27271056
[TBL] [Abstract][Full Text] [Related]
6. Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy.
Palli SR; Frazer M; DuCharme M; Buikema AR; Anderson AJ; Franchino-Elder J
J Manag Care Spec Pharm; 2020 Oct; 26(10):1363-1374. PubMed ID: 32678719
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort.
Busch R; Han MK; Bowler RP; Dransfield MT; Wells JM; Regan EA; Hersh CP;
BMC Pulm Med; 2016 Feb; 16():28. PubMed ID: 26861867
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database.
Quint JK; Montonen J; Esposito DB; He X; Koerner L; Wallace L; de la Hoz A; Miravitlles M
Adv Ther; 2021 May; 38(5):2249-2270. PubMed ID: 33721209
[TBL] [Abstract][Full Text] [Related]
9. Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.
Israel E; Roche N; Martin RJ; Colice G; Dorinsky PM; Postma DS; Guilbert TW; van Aalderen WM; Grigg J; Hillyer EV; Burden A; von Ziegenweidt J; Thomas V; Price DB
Ann Am Thorac Soc; 2015 Jun; 12(6):798-806. PubMed ID: 25756308
[TBL] [Abstract][Full Text] [Related]
10. As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
Domingo C; Rello J; Sogo A
Drugs; 2019 Nov; 79(16):1729-1737. PubMed ID: 31584145
[TBL] [Abstract][Full Text] [Related]
11. Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization.
Bengtson LGS; Yu Y; Wang W; Cao F; Hulbert EM; Wolbeck R; Elliott CA; Buikema AR
J Manag Care Spec Pharm; 2017 Nov; 23(11):1149-1159. PubMed ID: 29083972
[TBL] [Abstract][Full Text] [Related]
12. Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β
Buhl R; FitzGerald JM; Busse WW
Respir Med; 2018 Oct; 143():82-90. PubMed ID: 30261998
[TBL] [Abstract][Full Text] [Related]
13. Tiotropium Respimat®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists.
McKeage K
Drugs; 2015 May; 75(7):809-16. PubMed ID: 25895466
[TBL] [Abstract][Full Text] [Related]
14. Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status.
Kerstjens HA; Moroni-Zentgraf P; Tashkin DP; Dahl R; Paggiaro P; Vandewalker M; Schmidt H; Engel M; Bateman ED
Respir Med; 2016 Aug; 117():198-206. PubMed ID: 27492532
[TBL] [Abstract][Full Text] [Related]
15. Effects of the addition of tiotropium on airway dimensions in symptomatic asthma.
Hoshino M; Ohtawa J; Akitsu K
Allergy Asthma Proc; 2016 Nov; 37(6):147-153. PubMed ID: 27931291
[TBL] [Abstract][Full Text] [Related]
16. The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.
Short PM; Williamson PA; Elder DHJ; Lipworth SIW; Schembri S; Lipworth BJ
Chest; 2012 Jan; 141(1):81-86. PubMed ID: 21799028
[TBL] [Abstract][Full Text] [Related]
17. A comparison of tiotropium, long-acting β
Vogelberg C; Goldstein S; Graham L; Kaplan A; de la Hoz A; Hamelmann E
Respir Res; 2020 Jan; 21(1):19. PubMed ID: 31931792
[TBL] [Abstract][Full Text] [Related]
18. Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy.
Allen-Ramey FC; Bukstein D; Luskin A; Sajjan SG; Markson LE
J Manag Care Pharm; 2006 May; 12(4):310-21. PubMed ID: 16792437
[TBL] [Abstract][Full Text] [Related]
19. Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 Phenotype.
Casale TB; Bateman ED; Vandewalker M; Virchow JC; Schmidt H; Engel M; Moroni-Zentgraf P; Kerstjens HAM
J Allergy Clin Immunol Pract; 2018; 6(3):923-935.e9. PubMed ID: 29174062
[TBL] [Abstract][Full Text] [Related]
20. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
Farne HA; Cates CJ
Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]